Molecular Imaging Program at Stanford – FDA Inspection, Apr 17, 2026

Record Details

This FDA Inspection record concerns Molecular Imaging Program at Stanford, with an inspection on April 17, 2026, issued by the San Francisco District Office, covering human drugs.

Company: Molecular Imaging Program at Stanford
Inspection Date: April 17, 2026
Product Type: Human Drugs
Office: San Francisco District Office
People: Matthew R. Clabeaux (Issuing Officer)
Sateesh Kum Sathigari (Issuing Officer)
Zachary L. Stamm (FDA Associated Person)

View Company Profile

ID · 6d9cc2e0-590c-43fd-8031-959c5ba5d7ec

Inspection Facts

Inspection number: 1313292
FDA center: Human Drugs
Project area: Generic Drug Evaluation
Outcome: Form 483 issued, view the record

FDA Citations

21 CFR 212.20(e)Written QA procedures established, followed
21 CFR 212.40(c)Use of reliable suppliers
21 CFR 212.50(c)(4)Each major production step
21 CFR 212.60(a)Testing procedures
21 CFR 212.60(b)Lab sampling and test procedures
21 CFR 212.70(d)(1)Laboratory determination completed

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Molecular Imaging Program at Stanford

FDA Inspection

Molecular Imaging Program at StanfordApril 17, 2026